T-Heart Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $2.92M

  • Investors
  • 1

T-Heart General Information

Description

Developer of a transcatheter tricuspid valve replacement system designed to eliminate tricuspid regurgitation in diseased and enlarged tricuspid valves. The company offers a proprietary anchoring structure, a biomimetic valve design, and a one-step implantation procedure, enabling patients with tricuspid valve disease to improve cardiac function and quality of life.

Contact Information

Website
theartvalve.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 74 Rue du Faubourg, Saint Antoine
  • 75012 Paris
  • France
+33 01
Primary Industry
Surgical Devices
Other Industries
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 74 Rue du Faubourg, Saint Antoine
  • 75012 Paris
  • France
+33 01

T-Heart Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

T-Heart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A1) 05-Jun-2026 $2.92M Completed Pre-Clinical Trials
5. Later Stage VC 01-Jun-2025 Completed Startup
4. Later Stage VC 03-Apr-2023 Completed Generating Revenue
3. Early Stage VC 16-Jul-2021 Completed Product Development
2. Early Stage VC 29-May-2020 $3.28M $6.68M Completed Product Development
1. Early Stage VC 19-Jul-2019 $3.4M $3.4M Completed Startup
To view T-Heart’s complete valuation and funding history, request access »

T-Heart Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Shares A
Shares A
To view T-Heart’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

T-Heart Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a transcatheter tricuspid valve replacement system designed to eliminate tricuspid regurgitation in disease
Surgical Devices
Paris, France
8 As of 2026

Aschheim, Germany
 

Or Yehuda, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

T-Heart Competitors (2)

One of T-Heart’s 2 competitors is TRiCares, a Venture Capital-Backed company based in Aschheim, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TRiCares Venture Capital-Backed Aschheim, Germany
Cardiovalve Formerly VC-backed Or Yehuda, Israel
You’re viewing 2 of 2 competitors. Get the full list »

T-Heart Patents

T-Heart Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023412838-A1 Loading system for a stent device Pending 20-Dec-2022
EP-4637633-A1 Loading system for a stent device Pending 20-Dec-2022
US-20260207361-A1 Loading system for a stent device Pending 20-Dec-2022
WO-2024132115-A1 Loading system for a stent device Inactive 20-Dec-2022
WO-2024132887-A1 Loading system for a stent device Inactive 20-Dec-2022 A61F2/9525
To view T-Heart’s complete patent history, request access »

T-Heart Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

T-Heart Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
iBionext Accelerator/Incubator Minority
To view T-Heart’s complete investors history, request access »

T-Heart FAQs

  • When was T-Heart founded?

    T-Heart was founded in 2018.

  • Where is T-Heart headquartered?

    T-Heart is headquartered in Paris, France.

  • What is the size of T-Heart?

    T-Heart has 8 total employees.

  • What industry is T-Heart in?

    T-Heart’s primary industry is Surgical Devices.

  • Is T-Heart a private or public company?

    T-Heart is a Private company.

  • What is the current valuation of T-Heart?

    The current valuation of T-Heart is .

  • What is T-Heart’s current revenue?

    The current revenue for T-Heart is .

  • How much funding has T-Heart raised over time?

    T-Heart has raised $19.7M.

  • Who are T-Heart’s investors?

    iBionext has invested in T-Heart.

  • Who are T-Heart’s competitors?

    TRiCares and Cardiovalve are competitors of T-Heart.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process